Skip to content

Serdexmethylphenidate

Azstarys (serdexmethylphenidate) is a small molecule pharmaceutical. Serdexmethylphenidate was first approved as Azstarys on 2021-05-07. It is used to treat attention deficit disorder with hyperactivity in the USA. Azstarys's patents are valid until 2037-12-09 (FDA).
Trade Name Azstarys
Common Name Serdexmethylphenidate
Indication attention deficit disorder with hyperactivity
Drug Class
Serdexmethylphenidate
Get full access now